Profile data is unavailable for this security.
About the company
Racura Oncology Ltd, formerly Race Oncology Limited, is an Australia-based Phase III clinical biopharmaceutical company with a focus on cancer care. The Company's lead asset, RCDS1 (E,E-bisantrene), is a small molecule anticancer agent that primarily functions via G4-DNA and RNA binding, leading to potent inhibition of the important cancer growth regulator MYC. RCDS1 has demonstrated therapeutic activity in cancer patients with a well characterized safety profile. The Company is advancing a formulation of RCDS1 (RC220) to address the high unmet needs of patients across multiple oncology indications, with Phase III clinical programs in acute myeloid leukemia (AML), a Phase I a/b program in mutant epidermal growth factor receptor non-small cell lung cancer (EGFRm NSCLC), and a Phase I a/b program in combination with the anthracycline doxorubicin, where the Company is focused on delivering both cardioprotection and enhanced anticancer activity for solid tumor patients.
- Revenue in AUD (TTM)788.42k
- Net income in AUD-4.79m
- Incorporated2011
- Employees--
- LocationRacura Oncology LtdLevel 36, Gateway 1, Macquarie PlaceSYDNEY 2000AustraliaAUS
- Phone+61 28051-3043
- Websitehttps://www.raceoncology.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ImmuneOnco Biopharmaceuticls Shanghi Inc | 22.96m | -61.99m | 357.39m | 195.00 | -- | 3.08 | -- | 15.57 | -0.8715 | -0.8715 | 0.3225 | 1.49 | 0.148 | -- | 3,865.48 | 813,859.90 | -40.09 | -- | -51.56 | -- | -- | -- | -270.79 | -- | -- | -- | 0.2236 | -- | 19,109.59 | -- | 16.76 | -- | -- | -- |
| Cogstate Ltd | 74.90m | 14.31m | 372.27m | 61.00 | 26.37 | 5.42 | 20.16 | 4.97 | 0.0823 | 0.0823 | 0.4305 | 0.40 | 0.866 | -- | 4.69 | -- | 16.55 | 11.82 | 20.98 | 16.38 | 60.53 | 56.32 | 19.11 | 14.87 | -- | -- | 0.0097 | -- | 22.25 | 18.44 | 86.15 | -- | -0.4007 | -- |
| Mabpharm Ltd | 86.83m | -5.63m | 380.36m | 383.00 | -- | 18.78 | 56.96 | 4.38 | -0.0076 | -0.0076 | 0.1164 | 0.0272 | 0.4209 | 0.4659 | 4.05 | 1,524,243.00 | -2.73 | -19.62 | -4.02 | -25.69 | 86.40 | -- | -6.48 | -211.59 | 0.6906 | -1.58 | 0.7552 | -- | 196.27 | -- | 38.89 | -- | -12.13 | -- |
| Jiangsu Recbio Technology Co Ltd | 2.23m | -133.93m | 381.67m | 507.00 | -- | 10.29 | -- | 170.98 | -1.55 | -1.55 | 0.0258 | 0.4247 | 0.006 | -- | -- | 23,246.88 | -36.26 | -31.31 | -64.03 | -37.31 | -- | -- | -5,990.59 | -- | 0.2767 | -100.74 | 0.8254 | -- | -- | -- | 1.67 | -- | 16.82 | -- |
| Racura Oncology Ltd | 788.42k | -4.79m | 390.26m | -- | -- | 23.33 | -- | 494.99 | -0.0282 | -0.0282 | 0.0043 | 0.0922 | 0.0418 | -- | 11.64 | -- | -25.38 | -41.75 | -27.84 | -44.07 | -- | -- | -607.20 | -2,015.76 | -- | -- | 0.00 | -- | -5.30 | 142.92 | 65.36 | -- | -- | -- |
| Frontage Holdings Corp | 357.61m | 5.42m | 397.65m | 1.54k | 73.11 | 0.8237 | 6.99 | 1.11 | 0.0148 | 0.0148 | 0.9736 | 1.31 | 0.4545 | 60.36 | 3.97 | 1,267,645.00 | 0.6902 | 3.05 | 0.8654 | 3.64 | 27.78 | 32.14 | 1.52 | 6.84 | 1.22 | 1.97 | 0.2861 | 0.00 | -1.90 | 20.48 | -92.68 | -46.72 | 13.29 | -- |
| Heartseed Inc | -925.60m | -925.60m | 407.49m | 39.00 | -- | 6.12 | -- | -- | -- | -- | -- | 314.76 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 22.15 | -- | 0.00004 | -- | -- | -- | -- | -- | -- | -- |
| Antengene Corp Ltd | 17.28m | -46.82m | 426.23m | 152.00 | -- | 2.72 | -- | 24.67 | -0.4166 | -0.4166 | 0.1538 | 1.28 | 0.0619 | 1.51 | 3.20 | 565,309.60 | -16.77 | -48.14 | -19.52 | -53.06 | 78.54 | -- | -271.00 | -1,460.93 | 4.41 | -- | 0.2346 | -- | 36.62 | -- | 45.07 | -- | 259.46 | -- |
